Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AINovember 17, 2026

BBP Virtus Biotech ETF

Fund tearsheet · data as of the latest session · November 17, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.34%expense ratio
$22Mfund assets
+24.3%return, YTD
—return, 1 year
—net flow, 1 month
—net flow, 1 year
27.0%realized volatility, 1y
-9.7%worst drawdown, 1y
Top ten holdings
1MRNA MODERNA6.11%
2XERS XERIS BIOPHARMA HOLDINGS3.23%
3OMER OMEROS2.71%
4VSTM VERASTEM2.71%
5IOVA IOVANCE BIOTHERAPEUTICS2.46%
6KNSA KINIKSA PHARMACEUTICALS2.44%
7ADMA ADMA BIOLOGICS2.12%
8REGN REGENERON PHARMACEUTICALS2.05%
9HALO HALOZYME THERAPEUTICS1.91%
10ZLAB ZAI LAB2.01%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.